Bradley Henry, MD
Internal Medicine · Charleston, WVNPI 1679573786
Payments from drug & device makers
Across 480 payments — averaging $17.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Novo Nordisk$924
- Boehringer Ingelheim$817
- Lilly USA, LLC$733
- Pfizer$420
- GSK$395
- plus $3K from 28 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 98 | $1,718 |
| Novo Nordisk | 53 | $924 |
| Boehringer Ingelheim | 54 | $817 |
| Lilly USA, LLC | 42 | $733 |
| Pfizer | 25 | $420 |
| GSK | 25 | $395 |
| Merck | 22 | $372 |
| AbbVie(2 entities) | 16 | $320 |
| Amgen(2 entities) | 19 | $286 |
| Sanofi-aventis U.S. LLC | 16 | $279 |
| Exact Sciences | 13 | $258 |
| Johnson & Johnson | 23 | $237 |
| Phathom Pharmaceuticals, Inc. | 7 | $193 |
| Abbott | 10 | $160 |
| Astellas Pharma US Inc | 5 | $156 |
| Dexcom, Inc. | 8 | $148 |
| Novartis | 7 | $123 |
| Amarin Pharma, Inc. | 8 | $117 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $91 |
| E.r. Squibb & Sons, L.L.C. | 5 | $81 |
| Organogenesis Inc. | 1 | $48 |
| Genentech USA, Inc. | 3 | $47 |
| Bayer | 2 | $38 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $32 |
| Recor Medical Inc | 1 | $30 |
| Biogen | 2 | $30 |
| Optinose US, Inc. | 1 | $25 |
| Sumitomo Pharma America, Inc. | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Avanir Pharmaceuticals, Inc. | 1 | $15 |
| Redhill Biopharma Inc. | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Esperion Therapeutics, Inc. | 1 | $13 |
| Idorsia Pharmaceuticals US Inc | 1 | $13 |
How this compares
$8,181 in reported general payments places this provider in the 90th percentile of 573 internal medicine providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other internal medicine in Charleston
- William ChapmanCharleston$1.7M
- Phillip TriplettCharleston$17K
- Roy BowdenCharleston$14K
- Richard CapitoCharleston$11K
- Ghali Ibrahim-BachaCharleston$9K
- Jack KinderCharleston$8K
- Brijal PatelCharleston$8K
- William JeffreyCharleston$7K
- Said HajouliCharleston$7K
- Justin BaileyCharleston$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.